---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-001352"
form_type: "8-K"
ticker: "ISCO"
cik: "0001355790"
company_name: "International Stem Cell CORP"
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:52:09.042836+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# International Stem Cell issues $2.9M promissory note to CEO Andrey Semechkin for working capital

## Summary
- Unsecured, non-convertible note for $2,900,000 issued to CEO/Co-Chairman on Jan 13, 2022.
- Replaces prior $2,650,000 note plus additional $250,000 provided by Dr. Semechkin.
- Interest rate of 4.5% per annum; principal and accrued interest due March 15, 2022.
- Borrower may prepay without penalty at any time.

## SEC filing metadata
- accession: 0001564590-22-001352
- form_type: 8-K
- ticker: ISCO
- cik: 0001355790
- company_name: International Stem Cell CORP
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/0001564590-22-001352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/isco-8k_20220113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-001352
- JSON: https://secwatch.observer/filing/0001564590-22-001352.json
- Plain text: https://secwatch.observer/filing/0001564590-22-001352.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.